Pharming Group reopens EMEA’s CB market

By Aidan Gregory
14 Jan 2020

Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company.

JP Morgan was sole global coordinator on the offering, which was launched early on Tuesday morning, and books closed at 11am in London.
Pharming Group’s five year bonds were marketed with an initial coupon range of 2.25% to 3%, and a conversion premium of  between 35% and 40% ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial